drugset / Trial / NCT06712602
PT150 Drug for Use in Alcohol Use Disorder
Phase 1
Recruiting
34 enrolled
Pop Test Oncology LLC
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabUniversity of Kentucky · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2028-07-31
- Completion
- 2028-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcohol | Other / unclassified | 0.5 g/kg | Oral |
| Subject | ORG 34517 | Small molecule | 0 mg | Oral |
| Subject | ORG 34517 | Small molecule | 225 mg | Oral |
| Subject | ORG 34517 | Small molecule | 450 mg | Oral |